All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

121

Reset

121 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BR1400-CPhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • CTX340Phase 21 trial

    CRISPR Therapeutics AG · Hypertension

  • DIAG723Phase 21 trial

    Diagonal Therapeutics, Inc. · Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension

  • HRS-9563Phase 21 trial

    Fujian Shengdi Pharmaceutical Co., Ltd. · Mild to Moderate Hypertension

  • IBI3016Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Hypertension

  • intraocular implant releasing timololTimoD implantPhase 21 trial

    EyeD Pharma · Glaucoma, Ocular Hypertension

  • PF-07868489Phase 21 trial

    Pfizer · Pulmonary Arterial Hypertension

  • PG043Phase 21 trial

    Alcon Research · Open Angle Glaucoma, Ocular Hypertension

  • REGN13335Phase 21 trial

    Regeneron · Pulmonary Arterial Hypertension (PAH)

  • REGN22530Phase 21 trial

    Regeneron · Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT)

  • ROC-101Phase 21 trial

    AllRock Bio, Inc. · Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease

  • RTN-001SLx-2101Phase 21 trial

    Retension Pharmaceuticals. Inc. · Uncontrolled Hypertension

  • SPC 2002Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology

  • SPC 2003Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology

  • SPC 2004Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology

  • SPC1001Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPC5002Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPC5003Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPC5004Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SYH2062Phase 21 trial

    CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Mild to Moderate Primary Hypertension

  • VB19055Phase 21 trial

    Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Hypertension, Resistant Hypertension, Uncontrolled Hypertension

NewerPage 3 of 3

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.